(Q35787807)

10 August 2017

1 reference

title

Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

10 August 2017

main subject

1 reference

1 reference

1 reference

1 reference

ORCID Public Data File 2021

author name string

Bulent O Yildiz

series ordinal

1

1 reference

10 August 2017

Olcay Gedik

series ordinal

2

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Reproductive BioMedicine Online

10 August 2017

published in

1 reference

10 August 2017

volume

8

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

649-656

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

The polycystic ovary syndrome: what does insulin resistance have to do with it?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Insulin release and peripheral sensitivity at the oral glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Influence of plasma glucose and insulin concentration on plasma glucose clearance in man

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

How to measure insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Gonadotrophin regimens and oocyte quality in women with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Impaired fasting glucose is not a risk factor for atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

The biological variation of insulin resistance in polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

The molecular mechanism of insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Diabetes prevalence and risk factors in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Carbohydrate Homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Mathematical modeling in glucose metabolism and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Repeatability characteristics of simple indices of insulin resistance: implications for research applications

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

The role of lifestyle modification in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Haemolysis affects insulin but not C-peptide immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Assessment of insulin sensitivity and insulin secretion from the oral glucose tolerance test in nonobese Japanese type 2 diabetic patients: comparison with minimal-model approach

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

The pathophysiology of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

The assessment of insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961645-8

7 January 2021

10.1016/S1472-6483(10)61645-8

Identifiers

DOI

1 reference

10 August 2017

1 reference